Receipt of anti-SARS-CoV-2 pharmacotherapies among non-hospitalized U.S. Veterans with COVID-19, January 2022 to January 2023

Lei Yan, Elani Streja, Yuli Li, Nallakkandi Rajeevan, Mazhgan Rowneki, Kristin Berry, Denise M. Hynes, Francesca Cunningham, Grant D. Huang, Mihaela Aslan, George N. Ioannou, Kristina L. Bajema
doi: https://doi.org/10.1101/2023.05.03.23289479

Article usage

Article usage: May 2023 to December 2024

AbstractFullPdf
May 2023470989
Jun 202338510
Jul 202330110
Aug 202321109
Sep 20232047
Oct 20231653
Nov 202327113
Dec 20231602
Jan 20241415
Feb 20241312
Mar 2024703
Apr 2024833
May 20242277
Jun 202415110
Jul 2024636
Aug 20241101
Sep 20241145
Oct 20241313
Nov 2024716
Dec 20241623
Back to top
Posted May 05, 2023.
Download PDF
Data/Code
Email
Receipt of anti-SARS-CoV-2 pharmacotherapies among non-hospitalized U.S. Veterans with COVID-19, January 2022 to January 2023
Lei Yan, Elani Streja, Yuli Li, Nallakkandi Rajeevan, Mazhgan Rowneki, Kristin Berry, Denise M. Hynes, Francesca Cunningham, Grant D. Huang, Mihaela Aslan, George N. Ioannou, Kristina L. Bajema
medRxiv 2023.05.03.23289479; doi: https://doi.org/10.1101/2023.05.03.23289479
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area